医疗AI初创公司Healthleap宣布完成3800万美元融资，用于推进其患者风险识别平台的开发与部署1。本轮融资包括800万美元种子轮和3000万美元A轮，其中种子轮由Sequoia Capital和First Round Capital共同领投，A轮由Hummingbird Ventures领投1。
Healthleap成立于2022年，由兄妹Jemima和Josiah Meyer创立，总部位于南非1。公司开发的AI平台通过分析患者医疗记录来识别未被确诊的疾病风险。该平台已在超过50家医院部署，合作机构包括Penn Medicine、Cedars-Sinai、Intermountain、Houston Methodist和Emory Healthcare1。过去一年内，医院合作伙伴数量从3家增长到50家以上，收入增长超过10倍1。
根据Josiah Meyer的介绍，该平台每晚分析每位成人住院患者的记录，包括实验室结果、生命体征、体重、药物、饮食医嘱、诊断和临床医生笔记等1。
在经济效益方面，宾大医院的试点项目产生了2380万美元的年化财务影响，其中630万美元来自额外报销，1750万美元来自缩短住院时间1。所有现有客户都实现了5倍或更高的投资回报率，某些情况下年度总回报率超过20倍1。Healthleap的长期目标是扩展平台覆盖40多种主要健康状况，并将服务扩展到门诊和家庭护理领域1。
Healthleap, a healthcare AI startup, has closed a combined $38 million funding round consisting of an $8 million seed round led by Sequoia Capital and First Round Capital, and a $30 million Series A round led by Hummingbird Ventures.1 The company, founded in 2022 by siblings Jemima and Josiah Meyer and headquartered in South Africa, has developed an artificial intelligence platform designed to analyze patient medical records and identify previously undiagnosed disease risks.1
The platform has already demonstrated significant clinical and financial impact across its growing hospital network.1 Healthleap's technology is now deployed across more than 50 hospitals, including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare.1 Over the past year, the company has expanded its hospital partnerships from three to more than fifty, while revenue has grown more than tenfold.1 A study from Penn Medicine showed the platform generated $23.8 million in annualized financial impact, comprising $6.3 million from additional reimbursements and $17.5 million from reduced hospital stays.1 All current clients have achieved a return on investment of at least 5 times or higher, with some achieving total annual ROI exceeding 20 times.1
According to Josiah Meyer, "Each night we analyze the records of every adult inpatient: lab results, vital signs, weight, medications, dietary orders, diagnoses, and clinical notes."1 Looking ahead, the company plans to expand coverage to more than forty major health conditions and extend its capabilities into outpatient and home care settings.1
评论
还没有评论，欢迎留下第一条。